BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22728936)

  • 1. TBX5 drives Scn5a expression to regulate cardiac conduction system function.
    Arnolds DE; Liu F; Fahrenbach JP; Kim GH; Schillinger KJ; Smemo S; McNally EM; Nobrega MA; Patel VV; Moskowitz IP
    J Clin Invest; 2012 Jul; 122(7):2509-18. PubMed ID: 22728936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional Patterning of the Ventricular Cardiac Conduction System.
    Burnicka-Turek O; Broman MT; Steimle JD; Boukens BJ; Petrenko NB; Ikegami K; Nadadur RD; Qiao Y; Arnolds DE; Yang XH; Patel VV; Nobrega MA; Efimov IR; Moskowitz IP
    Circ Res; 2020 Jul; 127(3):e94-e106. PubMed ID: 32290757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer.
    van den Boogaard M; Wong LY; Tessadori F; Bakker ML; Dreizehnter LK; Wakker V; Bezzina CR; 't Hoen PA; Bakkers J; Barnett P; Christoffels VM
    J Clin Invest; 2012 Jul; 122(7):2519-30. PubMed ID: 22706305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irx3 is required for postnatal maturation of the mouse ventricular conduction system.
    Kim KH; Rosen A; Hussein SM; Puviindran V; Korogyi AS; Chiarello C; Nagy A; Hui CC; Backx PH
    Sci Rep; 2016 Jan; 6():19197. PubMed ID: 26786475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant Intronic Enhancer Controls
    Man JCK; Bosada FM; Scholman KT; Offerhaus JA; Walsh R; van Duijvenboden K; van Eif VWW; Bezzina CR; Verkerk AO; Boukens BJ; Barnett P; Christoffels VM
    Circulation; 2021 Jul; 144(3):229-242. PubMed ID: 33910361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control.
    Rathjens FS; Blenkle A; Iyer LM; Renger A; Syeda F; Noack C; Jungmann A; Dewenter M; Toischer K; El-Armouche A; Müller OJ; Fabritz L; Zimmermann WH; Zelarayan LC; Zafeiriou MP
    Cardiovasc Res; 2021 Jul; 117(8):1908-1922. PubMed ID: 32777030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor ETV1 is essential for rapid conduction in the heart.
    Shekhar A; Lin X; Liu FY; Zhang J; Mo H; Bastarache L; Denny JC; Cox NJ; Delmar M; Roden DM; Fishman GI; Park DS
    J Clin Invest; 2016 Dec; 126(12):4444-4459. PubMed ID: 27775552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system.
    Moskowitz IP; Pizard A; Patel VV; Bruneau BG; Kim JB; Kupershmidt S; Roden D; Berul CI; Seidman CE; Seidman JG
    Development; 2004 Aug; 131(16):4107-16. PubMed ID: 15289437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease.
    Derangeon M; Montnach J; Cerpa CO; Jagu B; Patin J; Toumaniantz G; Girardeau A; Huang CLH; Colledge WH; Grace AA; Baró I; Charpentier F
    Cardiovasc Res; 2017 Apr; 113(5):464-474. PubMed ID: 28339646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease.
    Neu A; Eiselt M; Paul M; Sauter K; Stallmeyer B; Isbrandt D; Schulze-Bahr E
    Hum Mutat; 2010 Aug; 31(8):E1609-21. PubMed ID: 20564468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cx30.2 enhancer analysis identifies Gata4 as a novel regulator of atrioventricular delay.
    Munshi NV; McAnally J; Bezprozvannaya S; Berry JM; Richardson JA; Hill JA; Olson EN
    Development; 2009 Aug; 136(15):2665-74. PubMed ID: 19592579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family.
    Kyndt F; Probst V; Potet F; Demolombe S; Chevallier JC; Baro I; Moisan JP; Boisseau P; Schott JJ; Escande D; Le Marec H
    Circulation; 2001 Dec; 104(25):3081-6. PubMed ID: 11748104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development.
    Moskowitz IP; Kim JB; Moore ML; Wolf CM; Peterson MA; Shendure J; Nobrega MA; Yokota Y; Berul C; Izumo S; Seidman JG; Seidman CE
    Cell; 2007 Jun; 129(7):1365-76. PubMed ID: 17604724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium.
    Remme CA; Verkerk AO; Hoogaars WM; Aanhaanen WT; Scicluna BP; Annink C; van den Hoff MJ; Wilde AA; van Veen TA; Veldkamp MW; de Bakker JM; Christoffels VM; Bezzina CR
    Basic Res Cardiol; 2009 Sep; 104(5):511-22. PubMed ID: 19255801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large permissive regulatory domain exclusively controls Tbx3 expression in the cardiac conduction system.
    van Weerd JH; Badi I; van den Boogaard M; Stefanovic S; van de Werken HJ; Gomez-Velazquez M; Badia-Careaga C; Manzanares M; de Laat W; Barnett P; Christoffels VM
    Circ Res; 2014 Aug; 115(4):432-41. PubMed ID: 24963028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction.
    Al Sayed ZR; Canac R; Cimarosti B; Bonnard C; Gourraud JB; Hamamy H; Kayserili H; Girardeau A; Jouni M; Jacob N; Gaignerie A; Chariau C; David L; Forest V; Marionneau C; Charpentier F; Loussouarn G; Lamirault G; Reversade B; Zibara K; Lemarchand P; Gaborit N
    Cardiovasc Res; 2021 Jul; 117(9):2092-2107. PubMed ID: 32898233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal arrhythmias in Tbx3-deficient mice reveal extreme dosage sensitivity of cardiac conduction system function and homeostasis.
    Frank DU; Carter KL; Thomas KR; Burr RM; Bakker ML; Coetzee WA; Tristani-Firouzi M; Bamshad MJ; Christoffels VM; Moon AM
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):E154-63. PubMed ID: 22203979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system.
    Bezzina CR; Rook MB; Groenewegen WA; Herfst LJ; van der Wal AC; Lam J; Jongsma HJ; Wilde AA; Mannens MM
    Circ Res; 2003 Feb; 92(2):159-68. PubMed ID: 12574143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model.
    Leoni AL; Gavillet B; Rougier JS; Marionneau C; Probst V; Le Scouarnec S; Schott JJ; Demolombe S; Bruneval P; Huang CL; Colledge WH; Grace AA; Le Marec H; Wilde AA; Mohler PJ; Escande D; Abriel H; Charpentier F
    PLoS One; 2010 Feb; 5(2):e9298. PubMed ID: 20174578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common genetic variant within SCN10A modulates cardiac SCN5A expression.
    van den Boogaard M; Smemo S; Burnicka-Turek O; Arnolds DE; van de Werken HJ; Klous P; McKean D; Muehlschlegel JD; Moosmann J; Toka O; Yang XH; Koopmann TT; Adriaens ME; Bezzina CR; de Laat W; Seidman C; Seidman JG; Christoffels VM; Nobrega MA; Barnett P; Moskowitz IP
    J Clin Invest; 2014 Apr; 124(4):1844-52. PubMed ID: 24642470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.